SCHEMBL6928574

SCHEMBL6928574

O=C(Nc1cccs1)c1cccc2ccccc12

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 3/20 0.56
KMT2A Q03164 3/20 0.56
NPC1 O15118 2/20 0.56
RAB9A P51151 2/20 0.56
MMP3 P08254 1/20 0.56
HDAC8 Q9BY41 1/20 0.56
DEGS1 O15121 1/20 0.55
PLK1 P53350 1/20 0.54
CNR1 P21554 1/20 0.51
ALDH1A1 P00352 1/20 0.51
SMN1; SMN2 Q16637 2/20 0.49
NR1H4 Q96RI1 1/20 0.49
GFER P55789 1/20 0.49
KDM4E B2RXH2 1/20 0.49
MAPT P10636 1/20 0.49
PDE5A O76074 1/20 0.48
PDE1A P54750 1/20 0.48
PDE1B Q01064 1/20 0.48
PDE1C Q14123 1/20 0.48
NPSR1 Q6W5P4 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22720444 0.78 GAA (0.57) MEN1KMT2ANPC1RAB9AALDH1A1
SCHEMBL12857910 0.77 MEN1 (0.72) MEN1KMT2ANPC1RAB9AMMP3
SCHEMBL5190975 0.77 NPC1 (0.48) MEN1KMT2ANPC1RAB9AHDAC8
SCHEMBL10351939 0.76 METAP2 (0.58) MEN1KMT2ANPC1RAB9AALDH1A1
SCHEMBL11842236 0.75 MMP3 (0.65) MEN1KMT2ANPC1RAB9AMMP3
SCHEMBL21275460 0.75 RAB9A (0.76) MEN1KMT2ANPC1RAB9AMMP3
SCHEMBL368228 0.75 DEGS1 (0.78) MEN1KMT2ANPC1RAB9AMMP3
SCHEMBL31150345 0.75 DEGS1 (0.78) MEN1KMT2ANPC1RAB9AMMP3
SCHEMBL1890491 0.75 HDAC8 (0.64) MEN1KMT2ANPC1RAB9AMMP3
SCHEMBL21532933 0.75 PARP1 (0.54) MEN1KMT2ANPC1RAB9AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6562840-B1 Non-peptidic inhibitors of proteolytic enzymes such as urokinase 3-DIMENSIONAL PHARMACEUTICALS, INC. 2003-05-13 US disclosed
US-6515002-B2 4-(4-(1-phenyl-5-propylpyrazol4-yl)(1,3-thiazol-2-yl))-5 -methylthiothiophene-2-carboxamidine, for example; complement inhibitors; treating tissue damage, inflammation, or autoimmune diseases 3-DIMENSIONAL PHARMACEUTICALS, INC. 2003-02-04 US disclosed
US-6403633-B2 USEFUL ANTIANGIOGENIC, ANTIARTHRITIC, ANTIINFLAMMATORY, ANTIRESTENOTIC, ANTIINVASIVE, ANTIMETASTIC, ANTIOSTEOPOROTIC, ANTIRETINOPATHIC, CONTRACEPTIVE AND TUMORISTATIC TREATMENT AGENTS 3-DIMENSIONAL PHARMACEUTICALS, INC. 2002-06-11 US disclosed
US-6291514-B1 Heteroaryl amidines, methylamidines and guanidines, preparation thereof, and use thereof as protease inhibitors 3-DIMENSIONAL PHARMACEUTICALS, INC. 2001-09-18 US disclosed